[Federal Register: February 23, 2001 (Volume 66, Number 37)]
[Notices]               
[Page 11305]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23fe01-89]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
Meeting of the Recombinant DNA Advisory Committee

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee (RAC) and a Safety Symposium on 
Gene Transfer Research.
    The Safety Symposium on Gene Transfer Research will be held from 8 
a.m. to 6 p.m. on March 7, 2001 at the Doubletree Hotel, 1750 Rockville 
Pike, Rockville, MD 20852. The symposium will explore safety 
considerations in the Use of Adeno-Associated Virus Vectors in Gene 
Transfer Clinical Trials.
    The RAC meeting will be held from 8:30 a.m. to 5:30 p.m. on March 
8, 2001 at the National Institutes of Health (NIH), Building 31, C 
Wing, Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892. The 
Committee will review selected human gene transfer protocols; a 
proposed action to amend the NIH Guidelines with regard to NIH policy 
on serious adverse event reporting; data management activities related 
to human gene transfer clinical trials; and other matters to be 
considered by the Committee.
    Both meetings are open to the public with attendance limited to 
space available. Draft meeting agendas and other information will be 
posted at the Office of Biotechnology Activities' website: http://
www4.od.nih.gov/oba
    Individuals who wish to provide public comments or who plan to 
attend the meeting and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify Kelly 
Fennington, Program Analyst, Office of Biotechnology Activities by 
telephone at 301 496-9838 or E-mail at FenningK@od.nih.gov

    Dated: February 13, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-4455 Filed 2-22-01; 8:45 am]
BILLING CODE 4140-01-M